The aging brain is not a uniformly declining brain. Different regions age at different rates, and the pattern is roughly the inverse of the developmental order — the regions that matured last tend to age first. This last-in, first-out principle has direct clinical implications for how cognitive changes present and progress.
Prefrontal cortex volume declines earliest, beginning in middle age and continuing through later life. The clinical correlate is a gradual decline in executive function — working memory becomes leakier, task-switching slows, mental flexibility narrows, multitasking becomes harder. Many older adults describe these changes as memory problems, but standard memory testing often reveals that the deficit is actually executive — they can encode and retrieve information, but they struggle to manipulate and integrate it under cognitive load.
Hippocampal volume declines later, typically becoming clinically meaningful in the seventies and beyond. When hippocampal aging is accelerated by Alzheimer's pathology, the clinical signature shifts from executive slowing to recent memory loss — the cardinal early symptom of Alzheimer's. Distinguishing normal aging from mild cognitive impairment from early Alzheimer's depends on recognizing this shift in pattern.
Primary sensory and motor cortex are relatively spared. Vision, hearing, basic touch, and primary motor function decline more from peripheral changes (lens opacity, cochlear hair cell loss, peripheral nerve attrition) than from cortical decline. The cortical machinery that handles these functions remains relatively intact even into the eighth and ninth decades.
White matter changes — small areas of demyelination, microvascular damage, and signal hyperintensities on MRI — accumulate with age and contribute to slowing of processing speed across all cognitive domains. Vascular risk factors (hypertension, diabetes, hyperlipidemia) accelerate white matter aging, which is why aggressive treatment of vascular risk is one of the more evidence-based dementia prevention strategies.
Cognitive reserve — the brain's ability to tolerate pathology before showing clinical symptoms — varies enormously between individuals. Higher education, lifelong intellectual engagement, social connection, physical exercise, and sleep all contribute to cognitive reserve. Two patients with identical Alzheimer's pathology can have markedly different clinical trajectories depending on their reserve.
Some functions improve with aging, contrary to the deficit-focused literature. Crystallized intelligence (accumulated knowledge and vocabulary) often peaks in middle age and remains stable into late life. Emotional regulation often improves with age — older adults report higher life satisfaction and lower emotional reactivity than younger adults on average. Wisdom, however defined, often increases. The aging brain loses some capacities and gains others.
Hold this for clinical practice. When an older patient brings a cognitive complaint, ask what they cannot do now that they could do before. The pattern reveals the substrate. Executive complaints with preserved memory point to normal aging or prefrontal-led pathology. Recent memory complaints point to hippocampal-led pathology. Both can coexist. The clinician's job is to characterize the pattern, not just the deficit.